pharma · T Cell Lymphoma · Diabetes Mellitus · CRSP
S.A
S.A.
S.A patent portfolio — 65 USPTO pharmaceutical patents (A61K/A61P) with grant dates, status, and loss-of-exclusivity filters.
Company details
- Status
- Public
- HQ
- San Lorenzo, EU
- Founded
- 2011
- Employees
- 50
- Programs
- 14
- Drugs
- 8
- Patents
- 65
S.A patents
65 pharmaceutical patents indexed for S.A. 0 expire within 24 months.
S.A has 65 pharmaceutical patents in our USPTO PatentsView index (A61K/A61P). 0 expire within 24 months — use filters for patent-cliff planning.
Patent portfolio
-
US 11135247
Materials and methods for engineering cells and uses thereof in immuno-oncology
granted -
US 11118195
Universal donor cells
granted -
US 11118196
Universal donor cells
granted -
US 11118177
Materials and methods for treatment of Usher syndrome type 2A and/or non-syndromic autosomal recessive retinitis pigmentosa (ARRP)
granted -
US 11116797
Universal donor cells
granted -
US 11116798
Universal donor cells
granted -
US 11104918
Universal donor cells
granted -
US 11083799
Materials and methods for treatment of hereditary haemochromatosis
granted -
US 11072792
Materials and methods for treatment of usher syndrome type 2A
granted -
US 11071755
Materials and methods for engineering cells and uses thereof in immuno-oncology
granted -
US 11013767
Materials and methods for engineering cells and uses thereof in immuno-oncology
granted -
US 10995328
Materials and methods for treatment of autosomal dominant cone-rod dystrophy
granted -
US 10881689
Materials and methods for engineering cells and uses thereof in immuno-oncology
granted -
US 10857184
Materials and methods for engineering cells and uses thereof in immuno-oncology
granted -
US 10736919
Materials and methods for engineering cells and uses thereof in immuno-oncology
granted -
US 10729725
Materials and methods for engineering cells and uses thereof in immuno-oncology
granted -
US 10662425
Materials and methods for treatment of autosomal dominant retinitis pigmentosa
granted
Frequently asked questions
How many patents does S.A have?
65 published patents match the current filter (all indexed). The full portfolio is indexed from USPTO PatentsView (A61K/A61P).
When do S.A patents expire?
0 patents in the full portfolio expire within 24 months. Use the expiring filters above or open individual patent pages for grant and expiration dates.